| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |